| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0140-6736(66)92829-7 |
| P698 | PubMed publication ID | 4162350 |
| P2093 | author name string | O Fjeldborg | |
| S Olsen | |||
| F Kissmeyer-Nielsen | |||
| V P Petersen | |||
| P2860 | cites work | THE SHWARTZMAN REACTION: PATHOGENETIC MECHANISMS AND CLINICAL MANIFESTATIONS. | Q35498122 |
| MORPHOLOGICAL ASPECTS OF RENAL HOMOGRAFT REJECTION | Q35517969 | ||
| The relation of anti-leukocyte antibodies to the homograft reaction: their occurrence in human sera | Q78250934 | ||
| Gum acacia for preparing suspensions of leukocytes | Q79317577 | ||
| P433 | issue | 7465 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | donor cell | Q107637879 |
| P304 | page(s) | 662-665 | |
| P577 | publication date | 1966-09-01 | |
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells | |
| P478 | volume | 2 |
| Q104070285 | A Europe wide acceptable mismatch program will enable transplantation of long waiting highly sensitised patients with a compatible donor |
| Q69208059 | A Serological, Clinical and Morphological Study of Eight Kidney Grafts in Three Patients |
| Q34206939 | A clinicopathological study of human liver allograft recipients harboring preformed IgG lymphocytotoxic antibodies |
| Q70115471 | A collaborative scheme for tissue typing and matching in renal transplantation |
| Q49157862 | Acute cerebral oedema during treatment of hyperglycaemia. An experimentsl model |
| Q35546323 | Acute liver allograft antibody-mediated rejection: an inter-institutional study of significant histopathological features |
| Q40778807 | Advances in human leukocyte antigens and transplantation |
| Q36639676 | Allograft outcomes in outbred mice |
| Q40720557 | Analogs of the murine white-graft reaction |
| Q40817152 | Analysis of the Humoral Immune Response to Human Leukocyte Antigens in Turkish Renal Transplant Candidates and Relationship Between Autoimmune Disorders |
| Q92129061 | Anti-HLA donor-specific antibodies in allogeneic stem cell transplantation: management and desensitization protocol |
| Q70559027 | Antibodies against cell membrane constituents in systemic lupus erythematosus and related diseases. I. Cytotoxic effect of serum from patients with systemic lupus erythematosus (SLE) for allogeneic and for autologous lymphocytes |
| Q47788071 | Antibodies and Human Transplant Rejection |
| Q73693815 | Antibodies eluted from acutely rejected renal allografts bind to and activate human endothelial cells |
| Q79299995 | Antibody binding to endothelial and epithelial antigens triggers pig-to-rabbit xenograft rejection and its absence results in atypical complement deposition |
| Q42574231 | Antibody mediated rejection of human liver allografts: transplantation across ABO blood group barriers |
| Q66879572 | Antibody-Dependent and Direct Lymphocyte-Mediated Cytotoxicity in Patients on Hemodialysis |
| Q37647235 | Antibody-mediated rejection after adult living-donor liver transplantation triggered by positive lymphocyte cross-match combination |
| Q94476124 | Antibody-mediated rejection after lung transplantation |
| Q69936725 | Apparent Success in Avoiding Hyperacute Rejection in a Renal Allograft |
| Q39989535 | Artificial Kidneys and Renal Transplantation |
| Q51016759 | Assessing risk in liver transplantation. Special reference to the significance of a positive cytotoxic crossmatch. |
| Q69275335 | Assessment of the cellular immune response to HL-A antigens in human renal allograft recipients |
| Q74233902 | Association between a positive flow cytometry crossmatch and the development of chronic rejection in primary renal transplantation |
| Q67232864 | Autologous transfusions in uraemic patients |
| Q39101892 | B Cell Immunity in Solid Organ Transplantation. |
| Q36432935 | B Cells, Antibodies, and More |
| Q41099135 | B-cell directed antibodies and delayed hyperacute rejection: A case report |
| Q74188576 | Benefits of new methods for detection of anti-HLA class I antibodies |
| Q35940411 | Biologic properties and detection of immune complexes in animal and human pathology |
| Q72406134 | Blood loss with twin-coil dialysis |
| Q70101509 | Cadaveric renal transplantation. An analysis of 65 cases |
| Q73500046 | Cardiac transplantation across a positive prospective lymphocyte cross-match in sensitized recipients |
| Q70219267 | Cell-mediated hyperacute rejection. III. Genetic determinants |
| Q41077570 | Cellular mechanisms of adaptation of grafts to antibody |
| Q36663036 | Chronic inflammation of the placenta: definition, classification, pathogenesis, and clinical significance |
| Q41485092 | Circulating antibodies in renal transplant recipients. |
| Q90428801 | Class and Kinetics of Weakly Reactive Pretransplant Donor-specific HLA Antibodies Predict Rejection in Kidney Transplant Recipients |
| Q72646681 | Clinical kidney transplants |
| Q100426458 | Clinical outcome of living donor kidney transplantation across simultaneous ABO and HLA incompatibility: Single center experience of first ten cases |
| Q24630322 | Clinical xenotransplantation |
| Q37377064 | Clotting changes, including disseminated intravascular coagulation, during rapid renal-homograft rejection |
| Q40744606 | Coagulation changes in sensitized canine renal allografts |
| Q59258027 | Combined liver and kidney transplantation against a positive cross match in a patient with multispecific HLA-antibodies |
| Q34205519 | Combined liver-kidney transplantation and the effect of preformed lymphocytotoxic antibodies |
| Q77176246 | Combined liver-kidney transplantation: long-term follow-up in 18 patients |
| Q38573616 | Complement Interception Across Humoral Incompatibility in Solid Organ Transplantation: A Clinical Perspective |
| Q39738014 | Complications of cyclosporin therapy |
| Q37360103 | Crossmatch testing in kidney transplantation: patterns of practice and associations with rejection and graft survival. |
| Q35160323 | Current policies in hepatic transplantation: candidacy of patients with alcoholic liver disease or preformed antidonor antibodies and a reappraisal of biliary duct reconstruction |
| Q40774167 | Cytokines and peripheral tolerance to alloantigen. |
| Q31149944 | Cytotoxic flow-cytometric crossmatches (flow-tox): A comparison with conventional cytotoxicity crossmatch techniques |
| Q41114618 | Delayed hyperacute rejection in recipients of kidney transplants from HLA identical sibling donors |
| Q42872373 | Desensitization and Heart Transplantation of a Patient With High Levels of Donor-Reactive Anti-Human Leukocyte Antigen Antibodies |
| Q64263915 | Detecting donor-specific antibodies: the importance of sorting the wheat from the chaff |
| Q73727331 | Detection and localization of non-HLA-ABC antigenic sites relevant to kidney rejection on endothelial cells |
| Q28075921 | Detection of HLA Antibodies in Organ Transplant Recipients - Triumphs and Challenges of the Solid Phase Bead Assay |
| Q71833690 | Detection of antibodies to transplantation antigens by platelet aggregometry |
| Q69363779 | Detection of antiplatelet antibody activity in patients with renal cortical necrosis |
| Q73895290 | Determination of the frequency of HLA antibody secreting B-lymphocytes in alloantigen sensitized individuals |
| Q74616666 | Development of anti-HLA-antibodies against intra-CREG-mismatches in renal transplant recipients |
| Q45048528 | Diagnosing brucellosis |
| Q35217382 | Differential function of major histocompatibility complex antigens in T-lymphocyte activation |
| Q36351978 | Differential roles of Mac-1+ cells, and CD4+ and CD8+ T lymphocytes in primary nonfunction and classic rejection of islet allografts |
| Q35388861 | Donor specific antibodies after transplantation |
| Q37435514 | Donor-specific antibodies. Clinical relevance of antibodies detected in lymphocyte crossmatches. |
| Q74480615 | Early and late impact of a positive flow cytometry crossmatch on graft outcome in primary renal transplant |
| Q34421508 | Effect of anticomplement agent K76 COOH on hamster-to-rat and guinea pig-to-rat heart xenotransplantation |
| Q70115273 | Effect of cyclosporin A on immunoglobulin class in patients receiving blood transfusions |
| Q93161825 | Effector and regulatory B cells in immune-mediated kidney disease |
| Q44726292 | Effects of cytotoxic sera on endothelium in vitro |
| Q44119191 | Emergencies in Renal Transplantation |
| Q69602886 | Evaluation of Methods for the Preparation of HL-A Antigen-Poor Blood |
| Q37831816 | Evaluation of the highly sensitized transplant recipient |
| Q33754516 | Evaluation of the humoral immune response to human leukocyte antigens in Brazilian renal transplant candidates |
| Q34396490 | Evidence for hyperacute rejection of human liver grafts: The case of the canary kidneys |
| Q35794605 | Evolution of HLA antibody detection: technology emulating biology |
| Q35021857 | Experimental glomerular endothelial injury in vivo |
| Q33207800 | Flow cytometric detection of complement-activating HLA antibodies |
| Q71722460 | Fulminant second-set allograft rejection and endoscopic findings following small bowel transplantation in the rat |
| Q47765912 | Fulminatingly progressive recurrent glomerulonephritis in a renal allograft |
| Q34826232 | Functional aspects of the rejection of transplanted kidneys |
| Q39914366 | HL-A Antigens in Clinical Transplantation |
| Q39935285 | HL-A Antigens, Antibody, and Complement in the Lymphocytotoxic Reaction |
| Q53769993 | HL-A histocompatibility. |
| Q33786811 | HLA Class Ia and Ib Polyreactive Anti-HLA-E IgG2a Monoclonal Antibodies (TFL-006 and TFL-007) Suppress Anti-HLA IgG Production by CD19+ B Cells and Proliferation of CD4+ T Cells While Upregulating Tregs |
| Q89472835 | HLA in transplantation |
| Q39368880 | HLA matching and corneal grafting |
| Q41101234 | HLA-A, HLA-B, and HLA-DRB1 Allele and Haplotype Frequencies in Renal Transplant Candidates in a Population in Southern Brazil. |
| Q40114996 | HLA-DR and Renal Transplantation |
| Q81962554 | Heat inactivation can differentiate between IgG and IgM antibodies in the pretransplant cross match |
| Q41139020 | Hemocoagulation disorders in kidney allotransplants, caused by preformed antirenal antibodies |
| Q40962923 | Histocompatibility (Hla) Antigens and Keratoplasty |
| Q39724520 | Histocompatibility Antigens in Human Organ Transplantation |
| Q36664637 | Histocompatibility in organ transplantation |
| Q40786070 | Histologic changes in preserved cadaveric renal transplants |
| Q43704476 | Histological diagnosis of rejection of renal homografts in man. |
| Q69305164 | Histology and fine structure of necrotic renal allografts in man |
| Q38154130 | Histopathological diagnosis of acute and chronic rejection in pediatric kidney transplantation |
| Q33930853 | Historic landmarks in clinical transplantation: conclusions from the consensus conference at the University of California, Los Angeles |
| Q24596303 | History of clinical transplantation |
| Q45963224 | Human leukocyte antigen and major histocompatibility complex class I-related chain A antibodies after kidney transplantation in Turkish renal transplant recipients. |
| Q36202286 | Human leukocyte antigen antibodies for monitoring transplant patients |
| Q70091252 | Human lymphocytotoxic and haemagglutinating activity against sheep and pig cells |
| Q53709163 | Human renal allografts. Analysis of lesions in long-term survivors. |
| Q39969663 | Human tissue transplantation |
| Q47784760 | Humoral Antibodies in Renal Allotransplantation in Man |
| Q47805567 | Humoral antibodies in canine renal transplantation |
| Q47752634 | Hyperacute Cortical Necrosis After Antibody Pretreatment of Syngeneic Rat Kidney Transplants |
| Q47766095 | Hyperacute kidney rejection in rabbits with lymphocytotoxic antibodies |
| Q43820799 | Hyperacute rejection and enhancement of rabbit-kidney allografts |
| Q53999266 | Hyperacute rejection of guinea-pig to rat cardiac xenografts. I. Morphology |
| Q39673995 | Hyperacute rejection of renal homografts: with particular reference to coaglation changes, humoral antibodies, and formed blood elements. |
| Q35534740 | Hyperacute rejection of the kidney in patients with a negative crossmatch |
| Q36077484 | Hyperacute renal allograft rejection in the primate. Therapeutic limitations of antiplatelet agents alone and combined with heparin |
| Q38022711 | Identification and therapeutic management of highly sensitized patients undergoing renal transplantation. |
| Q78081161 | IgG, but not IgM, mediates hyperacute rejection in hepatic xenografting |
| Q39941757 | Immune Complex Disease in Experimental Animals and Man |
| Q37953238 | Immunoadsorption in the sensitized transplant recipient |
| Q40150649 | Immunobiological determinants in organ transplantation |
| Q64972638 | Immunobiology of sensitization in transplant recipients. |
| Q47782056 | Immunological Aspects of Renal Allotransplantation |
| Q39984736 | Immunological principles of donor selection for human cardiac transplantation |
| Q40999293 | Immunology of renal transplantation |
| Q37106682 | Immunomodulation in transfused trauma patients |
| Q47130649 | Impact of Preformed Donor-Specific Anti-Human Leukocyte Antigen Antibody C1q-Binding Ability on Kidney Allograft Outcome. |
| Q66950488 | In vitro stimulation of tissue thromboplastin (factor III) activity in human monocytes by immune complexes and lectins |
| Q57705064 | In vivo platelet activation with in vitro hyperaggregability to arachidonic acid in renal allograft recipients |
| Q37678248 | Incompatible kidney transplantation: lessons from a decade of desensitization and paired kidney exchange |
| Q70106752 | Influence of HL-A incompatibility on cadaveric renal transplantation |
| Q90163135 | Influence of Preformed Antibodies in Liver Transplantation |
| Q35795157 | Interaction of antibody with Forssman antigen in guinea pigs. A mechanism of adaptation to antibody- and complement-mediated injury |
| Q38329048 | Intestine and multivisceral transplantation: current status and future directions. |
| Q54591846 | Intraoperative Blood Transfusions and Hyperacute Renal Allograft Rejection in a Presensitized Recipient |
| Q34420708 | Intraoperative blood transfusions in highly alloimmunized patients undergoing orthotopic liver transplantation |
| Q70013748 | Is HL-A typing of clinical significance in cadaver renal transplantation? |
| Q27023312 | Issues in solid-organ transplantation in children: translational research from bench to bedside. |
| Q90903430 | Jon van Rood: The pioneer and his personal view on the early developments of HLA and immunogenetics |
| Q39987308 | Kidney Transplantation: Patient Selection and Management |
| Q50120504 | Kidney and pancreas transplantation without a crossmatch in select circumstances--it can be done |
| Q39433504 | Kidney transplantatability across a positive cross-match. Cross-match assays and distribution of B lymphocytes in donor tissues |
| Q41169081 | Kidney transplantation in highly sensitized patients: reappraisal of etiology, evaluation, and management protocols |
| Q74209967 | Kinetics of the pregnancy-induced humoral and cellular immune response against the paternal HLA class I antigens of the child |
| Q44737335 | Letter: Au-SH antigen and lymphocyte transformation |
| Q44205099 | Letter: Cultured lymphoblastoid cell-lines and responsiveness in cadaveric renal transplantation |
| Q66904424 | Leukocyte antigens and their clinical significance |
| Q71783500 | Leukocyte isoantibodies. 3. Identification and characterization of monospecific HL-A antiserums for histocompatibility testing |
| Q81813232 | Liver recipients harbouring anti-donor preformed lymphocytotoxic antibodies exhibit a poor allograft survival at the first year after transplantation: experience of one centre |
| Q45139797 | Long-term survival after renal transplantation in humans: (with special reference to histocompatibility matching, thymectomy, homograft glomerulonephritis, heterologous ALG , AND RECIPIENT MALIGNANCY). |
| Q39324880 | Lymphocyte-dependent antibody and renal graft rejection |
| Q39315458 | Lymphocyte-dependent antibody cross-matching for transplant patients |
| Q33574621 | MICA diversity and linkage disequilibrium with HLA-B alleles in renal-transplant candidates in southern Brazil |
| Q34360517 | Managing the highly sensitized transplant recipient and B cell tolerance |
| Q37818832 | Mechanism, pathophysiology, diagnosis, and management of renal transplant rejection. |
| Q89801572 | Mechanisms Underlying Antibody-Mediated Rejection |
| Q40175023 | Mechanisms of Allograft Rejection: The Roles of Cytotoxic T-Cells and Delayed-Type Hypersensitivity |
| Q84456399 | Minimising the clinical impact of the alloimmune response through effective histocompatibility testing for organ transplantation |
| Q69177480 | Mixed Lymphocyte Culture in Histocompatibility Testing for Familial Renal Transplantation |
| Q45179109 | Modulation of anti-HLA antibody production following renal transplantation in sensitised, immunoadsorbed patients |
| Q38849321 | Monitoring alloimmune response in kidney transplantation |
| Q26826880 | Monoclonal antibody therapy and renal transplantation: focus on adverse effects |
| Q68890004 | Morphological studies on cellular detachment induced by antibody reactions directed against membrane associated antigens. An ultrastructural study |
| Q69249228 | Nature of hyperacute rejection |
| Q72394050 | Non-specific induction of cytotoxicity in normal human lymphocytes in vitro: studies of mechanism and specificity of the reaction |
| Q69246412 | Occurrence and cross-reactivity of heterophile antibodies and anti-kidney antibodies in kidney transplanted patients and patients with renal disease |
| Q69351894 | Organ Specificity in Hyperacute Rejection of Canine Heart and Kidney Allografts |
| Q39847438 | Organ transplantation and the immune response gene. Clinical correlations and donor requirements. |
| Q34275572 | Organ transplantation, past and present |
| Q34286210 | Organ transplantation--then and now |
| Q46185349 | Outcomes of Highly Sensitized Patients Undergoing Simultaneous Liver and Kidney Transplantation: A Single-Center Experience With Desensitization |
| Q44917185 | Papillary Necrosis in Renal Allografts-Report of 2 cases |
| Q40175037 | Pathogenetic Studies of Cardiac Allograft Rejection Using Inbred Rat Models |
| Q42735497 | Patterns of vascular damage in the antibody-mediated rejection of skin xenografts in the mouse. |
| Q34965144 | Personal Reflections in Transplantation |
| Q42938768 | Platelet thrombi in rejection episodes. |
| Q42589148 | Platelets in early hyperacute allograft rejection in kidneys and their modification by sulfinpyrazone (Anturan) therapy. An experimental study |
| Q35864546 | Platelets in hyperacute rejection of heterotopic cardiac allografts in presensitized dogs. An experimental study |
| Q41810051 | Potent immunosuppressive effects of heterologous antiimmunoglobulin serum |
| Q34823925 | Predictive parameters for in vivo alloreactivity |
| Q41807660 | Preformed antibodies in sensitized recipients: effect of immunoglobulin titer, class, and specificity on liver and heart allografts. |
| Q34423424 | Preformed lymphocytotoxic antibodies: the effects of class, titer and specificity on liver vs. heart allografts |
| Q95810427 | Presensitization patterns in renal allograft recipients-A correlation with graft outcome |
| Q41187288 | Presensitization patterns in renal allograft recipients—A correlation with graft outcome |
| Q40751916 | Prevention of hyperacute kidney rejection by decomplementation using purified cobra venom factor |
| Q70129244 | Prevention of leucocyte-antibody formation |
| Q34416701 | Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. |
| Q68193371 | Prolongation of pig-to-dog renal xenograft survival by modification of the inflammatory mediator response |
| Q40761767 | Prolongation of survival of renal xenografts by infusion of donor blood |
| Q69361028 | Prolonged Survival of Renal Allografts in Outbred Rabbits Treated with Donor Specific F(ab')2 Alloantibody |
| Q30544649 | Pros and cons for C4d as a biomarker |
| Q40015326 | Recent Advances in Techniques for Freezing Red Cells |
| Q36708983 | Regulation of allograft survival by inhibitory FcγRIIb signaling |
| Q47743487 | Relative Importance of Cellular and Humoral Immunity in Human Renal Transplantation |
| Q36350925 | Release of heparan sulfate from endothelial cells. Implications for pathogenesis of hyperacute rejection |
| Q69937296 | Relevance of HL-A Antigens to Acute Humoral Rejection of Multiple Renal Allotransplants |
| Q44210337 | Relevance of a positive crossmatch in liver transplantation |
| Q69208931 | Renal Transplantation in Rabbits. VIII: The Relationship between Lymphocytotoxic Antibodies, Renal IgG Deposits and the Renal Allograft Reaction in Rabbits Sensitized by Multiple Skin Grafts |
| Q34414954 | Renal Transplantation in the Presence of a Positive Cytotoxic Antibody |
| Q70101170 | Renal allotransplantation in presence of lymphocytotoxic antibodies |
| Q72753037 | Renal transplantation |
| Q39438415 | Renal transplantation and a positive serological cross-match |
| Q47775620 | Renal transplantation performed across a positive crossmatch: a single centre experience |
| Q72754220 | Role of blood transfusions on the induction of antibodies againsts recognition sites on T lymphocytes in renal transplant patients |
| Q26864255 | Role of complement and NK cells in antibody mediated rejection |
| Q72145369 | Role of humoral presenitization in human renal transplant rejection |
| Q42588226 | Selective plasmapheresis in dogs for delay of heterograft response |
| Q74407794 | Sensitisation to swine leukocyte antigens in patients with broadly reactive HLA specific antibodies |
| Q46311126 | Sensitivity, specificity and clinical relevance of different cross-matching assays in deceased-donor renal transplantation. |
| Q36778867 | Sensitized recipients exhibit accelerated but not hyperacute rejection of vascularized composite tissue allografts |
| Q37710374 | Sensitized renal transplant recipients: current protocols and future directions |
| Q42615620 | Shared cadaver donor-husband HLA class I mismatches as a risk factor for renal graft rejection in previously pregnant women |
| Q37396491 | Shwartzman reaction after human renal homotransplantation |
| Q88375262 | Soluble CD30, Acute Rejection, and Graft Survival: Pre- and 6-Month Post-Transplant Determinations-When Is the Best Time to Measure? |
| Q53536679 | Some landmarks in the evolution of transplantation. |
| Q36998799 | Specificities of antibodies eluted from human cadaveric renal allografts. Multiple mechanisms of renal allograft injury |
| Q69321996 | Spontaneous rupture of renal transplants |
| Q40104533 | Studies of HLA-DR with Relevance to Renal Transplantation* |
| Q68757001 | Studies on cellular and humoral immune factors in human renal transplantation |
| Q46216270 | Successful living related kidney transplantation across an anti-donor HLA antibody |
| Q70100694 | Successful renal allotransplantation in presence of lymphocytotoxic antibodies. Importance of preoperative cross-matching |
| Q72539950 | Successful renal transplantation in patients with T-cell reactivity to donor |
| Q34049330 | Successful sequential liver-kidney transplantation in a patient with performed lymphocytotoxic antibodies. |
| Q53966060 | Susceptibility of liver allografts to high or low concentrations of preformed antibodies as measured by flow cytometry. |
| Q48397261 | The 25th anniversary of the Eurotransplant Acceptable Mismatch program for highly sensitized patients |
| Q34315278 | The Denver-Pittsburgh liver transplant series |
| Q50042370 | The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation |
| Q33850125 | The Future of Xenotransplantation |
| Q43505717 | The HL-A system and its clinical significance |
| Q71276516 | The HL-A transplantation system |
| Q36369256 | The Presence of Anti-HLA Antibodies before and after Allogeneic Hematopoietic Stem Cells Transplantation from HLA-Mismatched Unrelated Donors. |
| Q37722911 | The Privilege of Induction Avoidance and Calcineurin Inhibitors Withdrawal in 2 Haplotype HLA Matched White Kidney Transplantation |
| Q45338123 | The Veterans Administration |
| Q34985072 | The antibody crossmatch in liver transplantation |
| Q34422862 | The biological basis of and strategies for clinical xenotransplantation |
| Q37107243 | The blood transfusion effect: clinical aspects |
| Q40809056 | The cell type mediating hyperacute rejection of allogeneic mouse skin grafts |
| Q73465298 | The clinical importance of alloantibody-mediated rejection |
| Q38289184 | The clinical relevance of alloantibody in liver transplantation |
| Q39885689 | The correlation between humoral antibodies and rejection after renal transplantation |
| Q34330582 | The definition of ABO factors in transplantation: relation to other humoral antibody states |
| Q34330601 | The development of clinical renal transplantation |
| Q33993445 | The effect of FK-506 on hyperacute rejection in presensitized rats |
| Q34106158 | The generation and maintenance of serum alloantibody. |
| Q71769742 | The humoral immune response towards HLA class II determinants in renal transplantation |
| Q68095854 | The influence of cyclosporin A on alloantibody responses in inbred rats: provisional evidence for a serum factor with antiidiotypic activity |
| Q67353775 | The leucocyte migration technique as an assay of presensitization to human transplantation antigens |
| Q34050116 | The major histocompatibility system (MHS) in man |
| Q36129795 | The nature of experimental second-set kidney transplant rejection. 1. The role of coagulation in hyperacute (second-set) renal allotransplant rejection in dogs |
| Q39945561 | The nature of experimental second-set kidney transplant rejection. 3. The role of complement |
| Q36130356 | The nature of experimental second-set kidney transplant rejection. 6. The ultrastructural features: an immunological dilemma. |
| Q36078432 | The pathology of renal homograft rejection. A review |
| Q39915023 | The pathophysiology of renal allograft rejection: A collective review |
| Q38643487 | The present state of liver transplantation and the future prospects for intestinal transplantation |
| Q70415059 | The problem of leukocyte and thrombocyte reduction in blood preserves |
| Q39891673 | The production of lesions in the rabbit kidney by xenoperfusion with fresh human blood |
| Q35583534 | The role of B cells and alloantibody in the host response to human organ allografts |
| Q33891696 | The role of B cells in solid organ transplantation. |
| Q42145710 | The role of antibodies in the rejection and enhancement of organ allografts.?7318 |
| Q37363951 | The role of antibodies in transplantation |
| Q42579338 | The role of complement in the induction of acute antibody-mediated vasculitis of rat skin grafts in the mouse. |
| Q39919807 | The role of platelets in glomerulonephritis and transplantation |
| Q37711979 | The use of the kidney with an historical positive, and current negative crossmatch |
| Q39914622 | Tissue Typing in Human Kidney Transplantation: A Review |
| Q53740169 | Tissue matching and early rejection of cadaveric-donor renal allografts: the importance of unidentified donor antigens. |
| Q70111397 | Tissue typing and organ transplantation |
| Q92611093 | Towards uniformity in the definition of acceptable mismatches for highly sensitized patients |
| Q42984804 | Transfusion support of the transplant patient. |
| Q47610172 | Transfusion therapy for renal transplant candidates |
| Q36456960 | Transfusion-associated microchimerism: the hybrid within |
| Q36364261 | Transient perturbation of endothelial integrity induced by natural antibodies and complement |
| Q53965909 | Transplant accommodation in highly sensitized patients: a potential role for Bcl-xL and alloantibody. |
| Q48693408 | Transplant arteriopathy |
| Q68232494 | Transplantation |
| Q73678731 | Transplantation |
| Q34211751 | Transplantation immunology of penetrating keratoplasty. |
| Q33803804 | Transplantation immunology: solid organ and bone marrow |
| Q41275725 | Transplantation: the realization of a dream |
| Q27021397 | Treatment options and strategies for antibody mediated rejection after renal transplantation |
| Q40104185 | Typing for Human Alloantigens with the Primed Lymphocyte Typing Technique |
| Q69209908 | Ultrastructure of hyperacute rejection of xenogeneic liver grafts |
| Q34657886 | Understanding the pathogenesis and the pathology of hyperacute cardiac rejection |
| Q34498162 | Unsuccessful attempts to control hyperacute rejection of human renal homografts with F(ab') 2 and citrate organ pretreatment |
| Q41986546 | Varying expression of major histocompatibility complex antigens on human renal endothelium and epithelium. |
| Q46313692 | Vascular endothelial cell apoptosis induced by anti-donor non-MHC antibodies: a possible injury pathway contributing to chronic allograft rejection. |
| Q27024077 | Vascular endothelium as a target of immune response in renal transplant rejection |
| Q93074073 | WITHDRAWN: [Non anti-HLA antibodies and acute rejection: A critical viewpoint] |
| Q53984279 | Xenogenic transplantation of aortic segments. Korrelated serological and histological investigations of the rejection mechanism |
| Q35602802 | Xenotransplantation: a tool for reproductive biology and animal conservation? |
| Q79979170 | [Alloantibodies-mediated kidney transplant rejection: a pair of continuing approaches, and with nonetheless many open questions] |
| Q54269253 | [Observations in rejections of kidney transplants]. |
| Q83599621 | [Organ transplantation and blood transfusion] |
| Q71455665 | [Pathomorphology of transplant rejection and kidney biopsy diagnosis of the transplant] |
| Q79979192 | [The discovery of capillary Cd4 in kidney transplantation and the "renaissance" of humoral rejection] |
Search more.